Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2000
05/02/2000US6056964 Delaying or preventing the growth or spread of a malignant neoplasm by administering killed cells of mycobacterium vaccae
05/02/2000US6056960 Pertussis toxin and its analogs exhibiting adp-ribosyltransferase activity; tumor-related antigen comprising tumor cells, irradiated tumor cells, or tumor-associated antigens
05/02/2000US6055936 Sea cucumber carotenoid lipid fractions and process
05/02/2000CA2022740C Cyclic neurokinin a antagonists
05/02/2000CA2020838C Hemoregulatory peptides
05/02/2000CA2012480C Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
04/2000
04/27/2000WO2000023599A2 Human proteins involved in endoplasmic reticulum protein degradation
04/27/2000WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
04/27/2000WO2000023592A2 Minimal promoters and uses thereof
04/27/2000WO2000023584A1 Camel, an alternative translation product of the tumour antigen lage-1
04/27/2000WO2000023573A2 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies
04/27/2000WO2000023572A1 Tnfr related gene 12
04/27/2000WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
04/27/2000WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof
04/27/2000WO2000023468A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES
04/27/2000WO2000023466A2 Human rna binding proteins
04/27/2000WO2000023464A2 Zinc finger binding domains for gnn
04/27/2000WO2000023448A1 Novel pterin antineoplastic agents
04/27/2000WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000WO2000023430A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors
04/27/2000WO2000023426A1 Novel imidazoles with anti-inflammatory activity
04/27/2000WO2000023407A2 Ureido-thiobutyric acid derivatives as ppar-agonists
04/27/2000WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses
04/27/2000WO2000023112A1 Modulation of gene expression by combination therapy
04/27/2000WO2000023111A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
04/27/2000WO2000023109A1 Glypicans for the detection and treatment of human carcinoma
04/27/2000WO2000023108A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
04/27/2000WO2000023105A2 Adjuvant systems and vaccines
04/27/2000WO2000023096A2 Combination therapy with vip antagonist
04/27/2000WO2000023092A1 Contulakin-g, analogs thereof and uses therefor
04/27/2000WO2000023087A1 Polyspecific binding molecules and uses thereof
04/27/2000WO2000023074A1 Pharmaceutical composition containing decursin
04/27/2000WO2000023053A2 Artificial antigen-specific cells and related methods
04/27/2000WO2000023052A1 Liposome-entrapped topoisomerase inhibitors
04/27/2000WO2000004894A3 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
04/27/2000WO1999062909A9 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
04/27/2000WO1999061085A9 Method and compositions for treatment of cancers
04/27/2000WO1999006544A8 Membrane-bound cytokine compositions and methods of modulating an immune response using same
04/27/2000WO1998048838A8 Compounds
04/27/2000DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies
04/27/2000CA2773698A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
04/27/2000CA2622786A1 Neovascular-specific peptides
04/27/2000CA2594186A1 Pharmaceutical composition containing decursin
04/27/2000CA2348156A1 Human proteins involved in endoplasmic reticulum protein degradation
04/27/2000CA2348153A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
04/27/2000CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000CA2347654A1 Human rna binding proteins
04/27/2000CA2347409A1 Human proteins stam2a and stam2b and cdnas encoding these molecules
04/27/2000CA2347369A1 Minimal promoters and uses thereof
04/27/2000CA2347099A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
04/27/2000CA2347085A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
04/27/2000CA2347081A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
04/27/2000CA2347080A1 Tnfr related gene 12
04/27/2000CA2347003A1 Modulation of gene expression by combination therapy
04/27/2000CA2346942A1 Camel, an alternative translation product of the tumour antigen lage-1
04/27/2000CA2346879A1 Liposome-entrapped topoisomerase inhibitors
04/27/2000CA2346866A1 Combination therapy with vip antagonist
04/27/2000CA2346798A1 Novel neuropilin/growth factor binding and uses thereof
04/27/2000CA2346264A1 Glypicans for the detection and treatment of human carcinoma
04/26/2000EP0995757A2 Bivalent inhibitors of the proteasome
04/26/2000EP0995756A2 Mechanism oriented inhibitors of dipeptidyl peptidase I
04/26/2000EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
04/26/2000EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
04/26/2000EP0995448A1 Diagnostic agents and remedies for malignant tumors
04/26/2000EP0994966A1 Member of the tnf family useful for treatment and diagnosis of disease
04/26/2000EP0994959A1 Polymer-modified viruses
04/26/2000EP0994948A1 TGF$g(b) RII RECEPTOR NUCLEIC SEQUENCE, CODED PEPTIDE, AND USES
04/26/2000EP0994947A1 Mu-1, member of the cytokine receptor family
04/26/2000EP0994946A1 Coding sequence haplotypes of the human brca2 gene
04/26/2000EP0994903A1 Methods and compositions for galactosylated glycoproteins
04/26/2000EP0994895A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4
04/26/2000EP0994861A1 NEW $g(b)-AMINO AND $g(b)-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS
04/26/2000EP0994856A1 Inhibitors of farnesyl protein transferase
04/26/2000EP0994730A2 LABELLED FACTOR XIIIa SUBSTRATES
04/26/2000EP0994729A1 Use of intravenous contrast agents and devices for projection mammography
04/26/2000EP0994715A1 Difluoronucleoside phosphonic acids and derivatives thereof
04/26/2000EP0994708A1 Antagonists of gonadotropin releasing hormone
04/26/2000EP0994706A1 Method and compositions for administering taxanes orally to human patients
04/26/2000EP0994702A2 Medicament comprising adenosine
04/26/2000EP0994697A1 Rapamycin formulations for oral administration
04/26/2000EP0789716B1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
04/26/2000EP0771209A4 Novel peptides
04/26/2000EP0703909B1 Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them
04/26/2000EP0633930B1 In vitro generation of human dendritic cells
04/26/2000CN1251588A Novel 3,5 and/or 6 substituted analogues of swainsonine, process for their preparation and their use as therapeutic agents
04/26/2000CN1251532A Tissue factor methods and compositions for coagulation and tumor treatment
04/26/2000CN1251527A Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations
04/26/2000CN1251296A Use of anticancer material and production method of said anti-cancer material
04/26/2000CN1051703C Process for preparing medicinal composition containing oxaspiro [2,5] octane derivatives and its salt thereof
04/25/2000US6054560 Mitogen activated protein kinase, FRK
04/25/2000US6054555 Process for the preparation of immobilized and activity-stabilized complexes of LHRH antagonists
04/25/2000US6054470 Src family SH2 domain inhibitors
04/25/2000US6054468 Metastasis
04/25/2000US6054467 Induction of apoptosis in cancer cells following treatment with inhibitors of dna repair in combination with p53.
04/25/2000US6054449 Photodynamic therapy
04/25/2000US6054446 17-substituted-17-desoxy-1,3,5-estratrienes.
04/25/2000US6054439 Antisense olignucleotides having tumorigenicity-inhibiting activity
04/25/2000US6054437 Method for inducing death of neoplastic cells using piperazine derivatives
04/25/2000US6054432 Means for treating prostate hypertrophy and prostate cancer
04/25/2000US6054320 Includes a regent which binds to effector of arachidonic acid release in biopsy sample cells and another reagent for detectably labelling binding agent; for early, accurate diagnosis
1 ... 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 ... 2211